PHILADELPHIA, Sept. 4, 2012 /PRNewswire/ -- AFCell Medical announced today the results of a retrospective study of the use of an amnion based allograft membrane to prevent post-operative adhesions between the tendon, peritendonous structures and overlying skin. Of the fourteen study patients, 86% were clear of adhesions anywhere around the surgery site and 93% were adhesion free at the tendon repair site 1.7 years post-surgery, on average, and of those patients with signs of adhesions the effects were rated mild or moderate.
"It was a very positive result to find that amniotic membrane reduced adhesions following tendon surgery. This study confirmed my clinical experience over the past three years in reducing the adhesions and pain after tendon repair." – Dr. Richard Jay, Professor of Foot and Ankle Orthopedics, Temple University, Chief, Foot and Ankle Surgery, South Jersey Healthcare Hospital.
"Our data showed that less than 20% of the patients operated on with an AmnioClear overlay get adhesions on the surrounding tissues. Normally this is a very large problem in a variety of different surgical arenas, tendons being one of them." -- Dr. Adam Landsman, Assistant Professor of Surgery, Harvard Medical School, Chief Division of Podiatric Surgery, Cambridge Health Alliance.
The amnion based allograft material used in the study was AmnioClear, AFCell's proprietary amnion based allograft. AmnioClear is the only dry, shelf stable amnion based allograft processed under patent protected techniques. AmnioClear's processor is the leading tissue bank and supplier of allografts in the world, the Musculoskeletal Transplant Foundation.
About the Study
The 14 patient retrospective study was conducted by Dr. Richard Jay, Professor of Foot and Ankle Orthopedics, Temple University, and Dr. Adam Landsman
|SOURCE AFCell Medical|
Copyright©2012 PR Newswire.
All rights reserved